Clinical trial

Study on Lixisenatide and Counterregulation to Hypoglycemia

NCT02020629

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-01

PhasePHASE4

Study timeline

Study start (unknown)2013-12-01Date precision: month

Registry last updated2015-12-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

LixisenatideDRUG · verified · RxNorm: lixisenatide

Sponsors & collaborators

Lund Universitylead sponsor

Mapped research locations

MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02020629 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.